focus -WSS

focus

author：hotspot 2025-09-28 00:47:40 - browse：4

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： How digital therapeutics firms are pivoting after Pear's bankruptcy

focus

WSS

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Prior authorization will have to move faster under new Biden rule

Independent physicians launch a new lobbying group

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Elizabeth Holmes banned from government health programs

focus

focus

entertainment

Hollywood unions extend contract negotiations for actors

Research misconduct: Proposed new rules face resistance

What does generative AI mean for health care? We asked experts

Doctors increasingly discourage vaping amid mounting health concerns

Anesthesiologist group: stop taking Ozempic before surgery

New brain studies show LSD's effects on the brain in full color

Guidelines to prevent youth baseball injuries need more muscle

EU regulator recommends expanding Mounjaro approval to obesity

Duchenne breakthrough therapy leaves behind pioneering families

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

focus

Doctors increasingly discourage vaping amid mounting health concerns

Snowpack in the West is melting rapidly. Where will all that extra water go?

EU regulator recommends expanding Mounjaro approval to obesity

Medicare Advantage today, explained in one chart

Many immigrants are left out of maternal health programs

Judge orders hearing on Trump's motion to disqualify Fulton County DA

knowledge

focus

focus

focus